Upside – $VEEA +45.0% (regained full Nasdaq listing compliance following its reverse stock split) – $XRTX +21.0% (outlined planned FDA IND and Health Canada clinical-trial filings for XRx-026 in gout) – $SAIQ +19.5% (confirmed an October satellite launch advancing its post-quantum secure-communications roadmap) – $HUM +14.5% (2027 CMS Star Ratings exceeded its top-quartile revenue goal, …
Read in context ›Clover Health Investments Stock (CLOV)
Track Clover Health Investments stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
CLOV
Clover Health Investments
healthcare
At close
$4.79
â–² +0.21 (+4.59%)
Oct 9, 4:00 PM ET
After-hours
$4.80
â–² +0.01 (+0.22%)
Oct 9, 7:59 PM ET
Market Cap
$2.43B
P/E Ratio
—
1Y Return
+64.75%
EPS (TTM)
-$0.04
Read the latest TheStreet Pro articles mentioning Clover Health Investments, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning CLOV yet.
Daily Diary Mentions
1 mentionUpside, Downside Movers in the Morning